S-1

Company

Viking Therapeutics, Inc.

Filed

September 2, 2016

Accession Number

0000950123-16-020360

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →